156
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      scite_
       
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Incidence of mucormycosis rises in India due to COVID-19 in second wave of 2021

      research-article
      Bookmark

            Abstract

            Mucormycosis belongs to genus Mucor Rhizopus (M Rhizopus) and the following species are commonly isolated from patients are M Circinelloides, Rhizopus oryzae (R oryzae), R Microsporus, R Pusillus , Syncephalastrum Racemosum ( S Racemosum), S Variformis, Basidiolus ranarum ( B Ramarum), and Cunninghamella coronatus ( C coronatus). Common etiological agents of mucormycosis in India are Rhizopus species (65%), Mucor species (18%), Apophysomyces species (25%), and Lichtheimia (abasidia) species (5%). Mucormycosis spores are found ubiquitously in soil, vegetable matters, and dusts but never in liquid has it grown. They are characterized by broad aseptate, pauci septate, ribbon like hyphae structure with branching at 90 degree, grows rapidly in sabroid agar culture medium

            Content

            Author and article information

            Journal
            Annals of Tropical Medicine & Public Health
            Africa Health Research Organization
            13 June 2022
            : 1
            : 1
            Affiliations
            [1 ] Calcutta School of Tropical Medicine, Kolkata, India
            Author notes
            Author information
            https://orcid.org/0000-0001-5430-3814
            Article
            10.36295/ATMPH/2022/0004
            e15a1ff3-d21f-42fb-9d1a-1ffc2f85bcaf

            This work has been published open access under Creative Commons Attribution License CC BY 4.0 , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Conditions, terms of use and publishing policy can be found at www.scienceopen.com .

            History
            : 1 June 2022
            : 11 June 2022

            All data generated or analysed during this study are included in this published article (and its supplementary information files).
            Infectious disease & Microbiology
            Mucormycosis,COVID-19,second wave,Mucor,Fungal infection

            References

            1. . Dexamethasone in Hospitalized Patients with Covid-19. New England Journal of Medicine. Vol. 384(8):693–704. 2021. Massachusetts Medical Society. [Cross Ref]

            2. Sterne Jonathan A. C., Murthy Srinivas, Diaz Janet V., Slutsky Arthur S., Villar Jesús, Angus Derek C., Annane Djillali, Azevedo Luciano Cesar Pontes, Berwanger Otavio, Cavalcanti Alexandre B., Dequin Pierre-Francois, Du Bin, Emberson Jonathan, Fisher David, Giraudeau Bruno, Gordon Anthony C., Granholm Anders, Green Cameron, Haynes Richard, Heming Nicholas, Higgins Julian P. T., Horby Peter, Jüni Peter, Landray Martin J., Le Gouge Amelie, Leclerc Marie, Lim Wei Shen, Machado Flávia R., McArthur Colin, Meziani Ferhat, Møller Morten Hylander, Perner Anders, Petersen Marie Warrer, Savovic Jelena, Tomazini Bruno, Veiga Viviane C., Webb Steve, Marshall John C.. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19. JAMA. Vol. 324(13)2020. American Medical Association (AMA). [Cross Ref]

            3. Prakash Hariprasath, Chakrabarti Arunaloke. Global Epidemiology of Mucormycosis. Journal of Fungi. Vol. 5(1)2019. MDPI AG. [Cross Ref]

            Comments

            Comment on this article